Search

everythinglearnresearchcommunity

for

Search:↓

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

Blocking certain brain processes reduces mating behavior in female rats.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Neurosteroids help control dopamine responses in the brain.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Finasteride reduces movement issues in Parkinson's disease rats.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Finasteride helps reduce pain and inflammation in animals.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Neurosteroids may help treat disorders with too much dopamine activity.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.